These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8104411)

  • 1. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Immunol Today; 1993 Jun; 14(6):322-6. PubMed ID: 8104411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Trends Pharmacol Sci; 1993 May; 14(5):213-6. PubMed ID: 8212318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
    Ishikawa H; Ochi H; Chen ML; Frenkel D; Maron R; Weiner HL
    Diabetes; 2007 Aug; 56(8):2103-9. PubMed ID: 17456848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
    Kuhn C; Weiner HL
    Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
    Chatenoud L
    Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.
    Ochi H; Abraham M; Ishikawa H; Frenkel D; Yang K; Basso AS; Wu H; Chen ML; Gandhi R; Miller A; Maron R; Weiner HL
    Nat Med; 2006 Jun; 12(6):627-35. PubMed ID: 16715091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The current and future outlook in immunosuppressive therapy for children].
    Goţia S; Ionescu C
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):35-42. PubMed ID: 9524654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies for the therapeutic induction of tolerance.
    Waldmann H; Qin S; Cobbold SP
    Immunol Ser; 1993; 59():85-99. PubMed ID: 8461402
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective immunosuppression.
    Adorini L; Guéry JC; Rodriguez-Tarduchy G; Trembleau S
    Immunol Today; 1993 Jun; 14(6):285-9. PubMed ID: 8104410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.
    Chatenoud L
    Curr Opin Immunol; 2005 Dec; 17(6):632-7. PubMed ID: 16214320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation.
    Chatenoud L
    Curr Opin Pharmacol; 2004 Aug; 4(4):403-7. PubMed ID: 15251136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of autoimmune disease with monoclonal anti-CD4 antibodies.
    Waldor MK
    Immunol Ser; 1989; 45():573-86. PubMed ID: 2577329
    [No Abstract]   [Full Text] [Related]  

  • 17. CD3-specific antibody-induced active tolerance: from bench to bedside.
    Chatenoud L
    Nat Rev Immunol; 2003 Feb; 3(2):123-32. PubMed ID: 12563296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymectomy: a potential therapeutic method for autoimmune diseases besides myasthenia gravis.
    Guo W; Zhao YP; Jiang YG; Fan SZ; Wang RW; Li ZP
    Med Hypotheses; 2008; 70(5):1072-3. PubMed ID: 18155855
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
    Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
    Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell targeted therapy in autoimmunity.
    Blank M; Shoenfeld Y
    J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.